Washington ExaminerLean R·
FDA launches mifepristone study after pressure from Trump’s right flank
The Food and Drug Administration has launched a safety review of mifepristone, the drug used for medicated abortions, according to the Wall Street Journal. The review comes as some anti-abortion advocates have grown increasingly frustrated with the Trump administration, arguing it has moved too slowly on promises to revisit federal abortion-pill regulations ahead of the […]
Read at Washington Examiner →
